Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

Open access

Abstract

Type 1 diabetes (T1D) results from progressive loss of pancreatic islet mass through autoimmunity targeted at a diverse, yet limited, series of molecules that are expressed in the pancreatic β cell. Identification of these molecular targets provides insight into the pathogenic process, diagnostic assays, and potential therapeutic agents. Autoantigen candidates were identified from microarray expression profiling of human and rodent pancreas and islet cells and screened with radioimmunoprecipitation assays using new-onset T1D and prediabetic sera. A high-ranking candidate, the zinc transporter ZnT8 (Slc30A8), was targeted by autoantibodies in 60–80% of new-onset T1D compared with <2% of controls and <3% type 2 diabetic and in up to 30% of patients with other autoimmune disorders with a T1D association. ZnT8 antibodies (ZnTA) were found in 26% of T1D subjects classified as autoantibody-negative on the basis of existing markers [glutamate decarboxylase (GADA), protein tyrosine phosphatase IA2 (IA2A), antibodies to insulin (IAA), and islet cytoplasmic autoantibodies (ICA)]. Individuals followed from birth to T1D showed ZnT8A as early as 2 years of age and increasing levels and prevalence persisting to disease onset. ZnT8A generally emerged later than GADA and IAA in prediabetes, although not in a strict order. The combined measurement of ZnT8A, GADA, IA2A, and IAA raised autoimmunity detection rates to 98% at disease onset, a level that approaches that needed to detect prediabetes in a general pediatric population. The combination of bioinformatics and molecular engineering used here will potentially generate other diabetes autoimmunity markers and is also broadly applicable to other autoimmune disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0705894104

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Research works printed but not linked: 1

  1. I Bergerot, C Souchier, C Thivolet Can R Acad Sci III 316, 1368–1373 (1993).

Cited by

See all 1,014

Metadata

Authors
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., & Hutton, J. C.
Affiliations
  • University of Colorado Denver (US)
  • Harvard University (US)
Venue
Proceedings of the National Academy of Sciences
Published
2007-10-23
Volume
104
Issue
43
Pages
17040-17045
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1993312496
Cited by
1,014
References
44
Citations by year
2026: 22 · 2025: 28 · 2024: 30 · 2023: 40 · 2022: 44 · 2021: 37 · 2020: 53 · 2019: 51 · 2018: 32 · 2017: 52 · 2016: 65 · 2015: 69 · 2014: 72 · 2013: 77 · 2012: 87
FWCI
32.25
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (DK57516)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057516, U19DK061248)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
type 1 diabetes, zinc transporter 8, SLC30A8, zinc transporters, autoantigens, autoantibodies, autoimmunity, pancreatic beta cells, islet autoimmunity, GADA, islet autoantibodies, prediabetes, autoimmunity markers, disease onset
MeSH terms
Zinc Transporter 8, Adolescent, Adult, Aged, Antibody Specificity, Epitopes, Autoantibodies, Autoantigens, Child, Child, Preschool, Diabetes Mellitus, Type 1, Female, Humans, Infant, Male, Middle Aged, Organ Specificity, Risk Factors, Autoimmunity, Age of Onset, Age Distribution, Oligonucleotide Array Sequence Analysis, Cation Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. https://app.cochat.ai/papers/10.1073/pnas.0705894104
The paper
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., & Hutton, J. C. (2007). The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0705894104

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.